Clinical trial
Second Follow-up Study of Participants (COPD Patients and Healthy Control Subjects) from the Cross-sectional Study "11-03 Ribolution" for the Evaluation of Predictive Biomarkers Based on Non-coding RNA
NCT04895124 is registered in ClinicalTrials.gov with Fraunhofer-Institute of Toxicology and Experimental Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Second Follow-up Study of Participants (COPD Patients and Healthy Control Subjects) from the Cross-sectional Study "11-03 Ribolution" for the Evaluation of Predictive Biomarkers Based on Non-coding RNA
- Lead sponsor
- Fraunhofer-Institute of Toxicology and Experimental Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 25, 2021
- Completion date
- March 30, 2023
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease